Smoking and Idiopathic Pulmonary Fibrosis
Open Access
- 19 February 2012
- journal article
- review article
- Published by Hindawi Limited in Pulmonary Medicine
- Vol. 2012, 1-13
- https://doi.org/10.1155/2012/808260
Abstract
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Cigarette smoking is one of the most recognized risk factors for development of IPF. Furthermore, recent work suggests that smoking may have a detrimental effect on survival of patients with IPF. The mechanism by which smoking may contribute to the pathogenesis of IPF is largely unknown. However, accumulating evidence suggests that increased oxidative stress might promote disease progression in IPF patients who are current and former smokers. In this review, potential mechanisms by which cigarette smoking affects IPF, the effects of cigarette smoking on accelerated loss of lung function in patients with IPF, key genetic studies evaluating the potential candidate genes and gene-environment (smoking) interaction, diagnosis, and treatment with emphasis on recently closed and ongoing clinical trials are presented.Keywords
This publication has 136 references indexed in Scilit:
- Fibrocytes: emerging effector cells in chronic inflammationNature Reviews Immunology, 2011
- Lung Volumes and Emphysema in Smokers with Interstitial Lung AbnormalitiesThe New England Journal of Medicine, 2011
- Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotypeLaboratory Investigation, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Identification of Early Interstitial Lung Disease in Smokers from the COPDGene StudyAcademic Radiology, 2010
- CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes/macrophagesProceedings of the National Academy of Sciences of the United States of America, 2007
- Adult-onset pulmonary fibrosis caused by mutations in telomeraseProceedings of the National Academy of Sciences of the United States of America, 2007
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences of the United States of America, 2006
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complexNature, 2002